Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled Phase II Trial Investigating SUNITINIB Versus Placebo in Patients With Chemorefractory Advanced Adenocarcinoma of the Stomach or Lower Esophagus Treated With Chemotherapy FOLFIRI

NCT01020630 is registered in ClinicalTrials.gov with PD Dr Markus Möhler as lead sponsor.

NCT NCT01020630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01020630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled Phase II Trial Investigating SUNITINIB Versus Placebo in Patients With Chemorefractory Advanced Adenocarcinoma of the Stomach or Lower Esophagus Treated With Chemotherapy FOLFIRI
Lead sponsor
PD Dr Markus Möhler
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
July 31, 2013
Enrollment
91 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma